LIFE:CA:TSX-Evolve Global Healthcare Enhanced Yield Fund Hedged Units (CAD)

ETF | Sector Equity |

Last Closing

CAD 19.6

Change

-0.12 (-0.61)%

Market Cap

CAD 0.21B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-14 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

-0.27 (-0.58%)

CAD 3.39B
ZWU:CA BMO Covered Call Utilities ETF

N/A

CAD 1.81B
XIT:CA iShares S&P/TSX Capped Informa..

N/A

CAD 0.78B
TXF:CA First Asset Tech Giants Covere..

+0.11 (+0.51%)

CAD 0.67B
HTA:CA Harvest Tech Achievers Growth ..

+0.08 (+0.44%)

CAD 0.65B
XHC:CA iShares Global Healthcare (CAD..

-0.71 (-1.07%)

CAD 0.54B
ZUT:CA BMO Equal Weight Utilities Ind..

-0.17 (-0.79%)

CAD 0.51B
XUT:CA iShares S&P/TSX Capped Utiliti..

-0.15 (-0.55%)

CAD 0.37B
CWW:CA iShares Global Water Common Cl..

+0.65 (+1.17%)

CAD 0.31B
COW:CA iShares Global Agriculture Com..

+0.14 (+0.21%)

CAD 0.27B

ETFs Containing LIFE:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.77% 82% B 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.77% 82% B 79% B-
Trailing 12 Months  
Capital Gain -9.26% 9% A- 13% F
Dividend Return 4.44% 75% C 63% D
Total Return -4.81% 9% A- 13% F
Trailing 5 Years  
Capital Gain -9.64% 17% F 29% F
Dividend Return 35.52% 85% B 91% A-
Total Return 25.89% 29% F 44% F
Average Annual (5 Year Horizon)  
Capital Gain 0.85% 17% F 34% F
Dividend Return 2.01% 6% D- 32% F
Total Return 1.16% 56% F 45% F
Risk Return Profile  
Volatility (Standard Deviation) 6.96% 97% N/A 85% B
Risk Adjusted Return 28.96% 26% F 43% F
Market Capitalization 0.21B 62% D 46% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.